Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05375643 · ClinicalTrials.gov registry record · NA
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
A NA study of Gastrointestinal Cancer and Thoracic Cancer, sponsored by Nadine McCleary, MD, MPH.
- Recruiting
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 3
- Study locations
NCT05375643 is a NA study of Gastrointestinal Cancer and Thoracic Cancer that is actively recruiting participants, run by Nadine McCleary, MD, MPH. The registered enrollment target is 210 participants, roughly in line with the 229-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target. The trial reports 3 study locations across 1 state.
The verdict
NCT05375643, a NA study of Gastrointestinal Cancer and Thoracic Cancer, is actively recruiting participants, sponsored by Nadine McCleary, MD, MPH.
- RECRUITING
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 3
- Study locations
Study Summary
SURGE aims to increase equity in clinical trial enrollment by addressing barriers to genomic testing, which is increasingly needed to assess precision clinical trial eligibility and access standard precision therapies. The study is an interventional pilot meant primarily to assess the feasibility of the intervention. The intervention is comprised of a patient navigator, text message questionnaire, and informational video.
Conditions Studied
Interventions
- BEHAVIORAL SURGE
Study Locations (3)
Massachusetts
- Dana Farber Cancer Institute - Boston
- Dana-Farber Cancer Institute at St. Elizabeth's Medical Center - Brighton
- Dana-Farber Cancer Instiute - Merrimack Valley - Methuen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2023-04-03 |
| Est. Completion | 2028-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05375643
The ClinicalTrials.gov registry entry for NCT05375643 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 229-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target. The listed sponsor is Nadine McCleary, MD, MPH, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 1 intervention - of which SURGE is the first listed.
NCT05375643 reports 3 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05375643 about?
NCT05375643 is a clinical study titled "SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)". SURGE aims to increase equity in clinical trial enrollment by addressing barriers to genomic testing, which is increasingly needed to assess precision clinical trial eligibility and access standard precision therapies. The study is an interventional pilot meant primarily to assess the feasibility of...
What is the current status of trial NCT05375643?
This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2023-04-03. Estimated completion is 2028-07-30.
What conditions does trial NCT05375643 study?
This clinical trial studies the following conditions: Gastrointestinal Cancer, Thoracic Cancer, Hematologic Cancer.
What interventions are being tested in trial NCT05375643?
The interventions under investigation include: SURGE (BEHAVIORAL).
Who is sponsoring clinical trial NCT05375643?
This trial is sponsored by Nadine McCleary, MD, MPH, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05375643 being conducted?
This trial has 3 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Improving Comprehensive Care of Cancer Patients
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
RECRUITING · NA
-
REmote Symptom COllection to improVE postopeRative Care
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.